GC Wellbeing

▶ The first clinical trial sample analysis provider to adopt LIMS

▶ To provide enhanced quality of pharmacokinetic, pharmacodynamic, and immunogenicity data from bioanalytic testing

YONGIN, SOUTH KOREA, 5 SEP. 2023 – GCCL, a Korean clinical trial sample analysis company, announced on Sep. 5th that it has adopted the Lab Information Management System for the first time in the sample analysis industry.

Thermo Scientific™ Watson™ LIMS by Thermo Scientific, which GCCL has adopted this time is a well-known software widely used by many global CROs, pharma companies and regulatory authorities. It is known to support the entirety of bioanalytic workflow from assay validation for pharmacodynamic analysis of biologics and chemical pharmaceuticals to sample analysis and reporting. According to GCCL, the company has even added the Immune Response Module that supports the immunogenicity analysis workflow in order to provide more enhanced bioanalytic services.

Song Hyun Yang, CEO of GCCL, said, “Striving for better data accuracy is at the core of our company as a sample analysis service provider.” And he added that “with the introduction of LIMS, we provide a high-quality sample analysis service that adheres to the global guidelines”.

With the server in place, GCCL is planning to complete the Computer System Validation (CSV) and start applying the system for pharmacodynamic analysis of chemical and biologic pharmaceuticals as well as for immunogenicity analysis of biopharmaceuticals from Q1 next year.